All The Microbiologist articles in Web Issue – Page 325
-
NewsMajor breakthrough against diabetes thanks to a microbial molecule that disarms inflammation
Researchers have uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a microbial metabolite called trimethylamine. TMA, produced by gut bacteria from dietary choline can block a key immune pathway and improve blood sugar control.
-
NewsClimate extremes triggered rare coral disease and mass mortality on the Great Barrier Reef
Marine biologists have identified a devastating combination of coral bleaching and a rare necrotic wasting disease that wiped out large, long-lived corals on the Great Barrier Reef during the record 2024 marine heatwave.
-
NewsNew study reveals that parasite-produced dopamine can alter host behaviour
A new study has shed light on how Toxoplasma gondii, the causative agent of toxoplasmosis, can alter host behaviour. The research findings show that such behavioural changes are achieved, at least in part, through dopamine manipulation caused by dopamine produced by the parasite itself.
-
NewsNature’s 10: Ten people who shaped science in 2025
Microbiologists and scientists tackling infectious diseases are among Nature’s annual list of ten people at the heart of some of the biggest science stories of 2025.
-
CareersFascinating exchange of ideas at 6th Plant Microbiome Symposium - and new collaborations are already starting
Last month Applied Microbiology International supported the 6th Plant Microbiome Symposium in Antequera, Spain, funding 17 travel grants for early career researchers to attend. Organiser Dr Victor Jose Carrion Bravo reports back on a vibrant exchange of ideas.
-
NewsAFYREN and ESSE Skincare begin partnership to offer 100% natural cosmetic solutions with enhanced skincare performance
AFYREN, a greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology, and South Africa-based Esse Skincare, a leader in microbiome skincare science, are partnering to introduce the world’s first bio-based propionic acid for the skincare industry.
-
NewsWhat are the new guidelines for infant hepatitis B vaccination?
Public health expert and infectious disease physician Janet A. Jokela comments after the Advisory Committee on Immunization Practices of the CDC voted to discontinue its decades-long recommendation for universal vaccination against hepatitis B beginning at birth.
-
NewsHow can nursing homes protect more patients from infections?
New US national guidance calls for full-time infection prevention staff; more training, support and vaccination for all staff; and partnerships with hospitals and public health agencies.
-
NewsNew study reveals how natural humic substances reshape soil carbon cycling and boost antibiotic resistance
Researchers have uncovered surprising links between natural humification processes in soil, carbon metabolism, and the spread of antibiotic resistance. Subtle shifts in the composition of humic substances can reshape microbial metabolism and alter the abundance of antibiotic resistance genes.
-
NewsOld molecules show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2 continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, researchers have identified several promising molecules that could lead to new medications capable of combating these resistant variants.
-
NewsYeast cell factory developed to convert methanol into L-lactate
Researchers developed a yeast cell factory to produce L-lactate from methanol as the sole carbon source, and evaluated the commercial potential and environmental impacts of this bioprocess.
-
NewsTuberculosis: Scientists develop novel drug candidate for combating resistant pathogens
Researchers have developed a promising new substance for targeting bacteria that cause tuberculosis. The team have produced a compound that inhibits the pathogens’ ability to produce energy and causes them to die.
-
NewsStudy unlocks the key microbes contributing to postnatal growth retardation
Postnatal growth retardation (PGR) has a high incidence during early postnatal development of piglets and humans. Researchers have found that hindgut-enriched Methanobrevibacter smithii compromises the weight gain in the pig PGR model.
-
NewsStudy reveals how bacteria resist hostile attacks from rival bacteria
When attacked by bacteria from a different species, Pseudomonas rapidly assembles the type VI secretion system (T6SS) – to inject its aggressor with a toxic cocktail. A new study probes how Pseudomonas can strike back when it has already been hit by a deadly cocktail itself.
-
NewsInside the gut: What our poo could tell us about our diet, gut microbes and health
Researchers have found that molecules in stool samples can accurately reflect what people eat and how their gut microbiome responds, offering a potential new tool to study nutrition and its impact on health.
-
NewsHow did Bronze Age plague spread? Ancient sheep might solve the mystery
Researchers have found the first evidence of a Bronze Age plague infection in a non-human host. The scientists discovered Y. pestis DNA in a 4,000-year-old domesticated sheep from Arkaim, a fortified settlement located in the Southern Ural Mountains of present-day Russia.
-
NewsStudy suggests that chlorine treatment may impact the risk of legionnaires’ disease
Preliminary results of a nationwide study suggest that the disinfectant used to treat water before it is distributed through pipes may impact the incidence of Legionnaire’s disease in certain parts of the country.
-
NewsParasitic fungus may have emerged 18 million years before the ants with which it lives today
An analysis of 309 strains indicates that the genus Escovopsis emerged 56.9 million years ago, but only began interacting with today’s mutualistic ants 38 million years ago, challenging the theory that they all emerged at the same time.
-
NewsCARB-X to support investigation of Exhalon’s breath-based lower respiratory tract infection testing platform
CARB-X has awarded Exhalon US$1M in seed funding to evaluate whether exhaled breath can be used as a non-invasive sample type to aid in the rapid and accurate diagnosis of lower-respiratory tract infections (LRTIs).
-
CareersSummer studentship: Lucy creates a synthetic microbiome to study mosquito-borne diseases at different life stages
Lucy Ella Malvern reports back on her AMI-sponsored summer studentship which investigated microbiome assembly in mosquitoes across developmental stages.